KMT2A and acute lymphoblastic leukemia: To assess the relationship between CXCR4 expression and chemosensitivity in ALL, Sison et al.[99] utilized primary samples from infants with mixed lineage leukemia (MLL)-rearranged ALL, a high-risk molecular subtype of B-ALL that is associated with poor outcomes.